NEW YORK (GenomeWeb) – Affymetrix reported after the close of the market today first quarter revenue growth of 7 percent, an increase the company attributed to the strong performance of its genotyping and reproductive health business.

For the three months ended March 31, the company's revenues increased to $88.7 million from $83 million in the year-ago quarter. On a constant currency basis, its revenues increased 9 percent year over year, and beat the average Wall Street estimate of $86.8 million.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Berkeley researchers have engineered yeast to make the molecule behind the hoppy taste of beer, Quartz reports.

King's College London researchers examine the influence of school type and genetics on academic achievement.

FiveThirtyEight writes that most who take a direct-to-consumer BRCA1/2 genetic test won't learn much from it.

In Science this week: early life experience influence somatic variation in the genome, and more.